Table 2.

ROC Curve Analyses of the Blood Cell Count-Derived Inflammation Indices Between MACE and non-MACE Groups.

Variable	AUC	SE	P-value	95%CI	Se (%)	Sp (%)	Cut off
AISI	0.624	0.036	.001	0.553-0.694	70.5	52.4	293.46
SIRI	0.625	0.037	<.001	0.552-0.698	54.1	71.8	2.45
NLRP	0.625	0.037	<.001	0.554-0.697	62.3	59.4	0.018
SII	0.626	0.034	<.001	0.561-0.692	75.4	49.3	628.60
dNLR	0.638	0.034	<.001	0.571-0.705	77.1	50.6	2.30
NLR	0.640	0.036	<.001	0.570-0.709	83.6	42.3	2.60
PLR	0.593	0.038	.014	0.518-0.668	29.5	85.7	225.49
MLR	0.598	0.042	.010	0.516-0.680	50.8	71.0	0.33

Abbreviations: ROC, receiver-operating characteristic; MACE, major adverse cardiovascular events; AUC, area under the curve; SE, standard error; CI, confidence interval; Se, sensitivity; Sp, specificity; AISI, aggregate index of systemic inflammation (neutrophil*platelet*monocyte-to-lymphocyte ratio); SIRI, systemic inflammation response index (neutrophil*monocyte-to-lymphocyte ratio); NLRP, neutrophil-to-(lymphocyte*platelet) ratio; SII, systemic immune-inflammation index (neutrophil*platelet-to-lymphocyte ratio); dNLR, derived neutrophil-to-lymphocyte ratio (neutrophil/(white blood cell–neutrophil)); NLR, neutrophil-to-lymphocyte ratio; PLR, platelet-to-lymphocyte ratio; MLR, monocyte-to-lymphocyte ratio.